MSB 3.21% $1.13 mesoblast limited

Ann: MSB Q2 Financial Results and Operational Highlights, page-216

  1. 117 Posts.
    lightbulb Created with Sketch. 113
    Hello Cato.
    I think you are being right in pointing out of the huge upside for Mesoblast if the approvals is for to going ahead. A little bit of the media positive will making big waves for the market cap of that only being one for approval. Imagine if more than one is getting approved for the outcome is huge in long run the. The message is going out i am thinking and the shorting is on edge because of price increase for to reducing the profitable of the shorters. At some point that will peaking and be reversal. Then share pricing may truly reflect what company is worth,, a lot more than currently factoring.
    Onwards and upward for the future!
    Regards,,,Royalsandman
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.